Capricor Therapeutics Inc (CAPR)
Healthcare
Biotechnology
3.90 $
-8.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Capricor Therapeutics Inc (CAPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.8% of the shares are freely tradable; institutional investors hold 59.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
59.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
9.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
83.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
22.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
58Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 6.59 | 3,818,600 | +113.9 | 03/31/2026 |
| BlackRock Inc | 5.91 | 3,421,815 | +20.0 | 03/31/2026 |
| TANG CAPITAL MANAGEMENT LLC | 5.87 | 3,399,900 | +100.0 | 03/31/2026 |
| Vanguard Group Inc | 4.42 | 2,561,880 | +16.1 | 12/31/2025 |
| State Street Corp | 3.77 | 2,181,901 | +163.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.50 | 2,027,732 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 2.60 | 1,507,844 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.93 | 1,118,326 | +9.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.58 | 1,489,075 | +1.7 | 04/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.25 | 1,297,308 | -0.6 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.